| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |